Research Article

Role of HLA-B Alleles and Clinical Presentation of B27 Negative Spondyloarthritis Patients from Mumbai, Western India

Table 1

Distribution of HLA-B alleles among B27 negative SpA patients and controls from Western India (patients ( ); controls ( )).

Serial numberHLA-B %PF %P.FOR95% CI Y value

1B*5110130.7430.309–1.7850.1960.506
2B*52780.8650.301–2.4850.0720.788
3B*0754185.3482.808–10.18626.5841.14E  − 07
4B*1519121.7200.785–3.7651.3740.171
5B*0812140.8370.366–1.9140.0440.674
6B*18690.6450.220–1.8870.2880.420
7B*13431.3470.293–6.1830.1480.700
8B*4017320.4350.222–0.8505.2980.013
9B*3533440.6260.353–1.1132.1120.109
10B*57971.3140.469–3.6780.0670.602
11B*58842.0800.607–7.1690.7970.233
12B*449150.5600.232–1.3481.1840.191
13B*47360.4840.117–1.9950.4650.306
14B*48205.1020.241–107.700.5050.155
15B*53111.0000.061–16.2240.0001.000
16B*49130.3260.033–3.1960.2550.312
17B*38010.3300.013–8.2051.0050.316
18B*78020.1960.009–4.1380.5050.155
19B*81130.3260.333–3.1960.2550.312
20B*37130.3260.333–3.1960.2550.312
21B*42010.3300.013–8.2051.0050.316
22B*56313.0620.312–29.9650.2550.312

N+: number positive, PF: phenotype frequency, OR: odds ratio, Y: chi-square with Yates’ correction.